VDRM — Viaderma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual cashflow statement for Viaderma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2007 December 31st	R2008 December 31st	2009 December 31st	2010 December 31st	2011 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.141	6.55	4.09	4.51	2.67
Depreciation
Non-Cash Items	0.108	0.006	1.26	0.862	0.002
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0	-1.12	-2.7	0.848	0.572
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Cash from Operating Activities	-0.031	5.86	3.31	7.78	6.05
Capital Expenditures	-0.01	-6.32	-5.52	-7.13	-9.43
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	0	0.005	0.002	0.004
Sale of Fixed Assets
Cash from Investing Activities	-0.01	-6.32	-5.52	-7.12	-9.43
Financing Cash Flow Items	0.004	-0.729	1.39	-0.937	0.252
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.043	0.122	2.72	-0.446	2.95
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.001	-0.308	0.509	0.196	-0.394